Endocrine Abstracts

Recently it has been shown that somatostatin (SST) might be of therapeutic value in the treatment of active Graves’ophthalmopathy (GO). SST and somatostatin receptors (sst) transcripts are expressed and functional in cultured orbital fibroblasts deriving from GO patients (FGO). Octreotide, the SST analogue currently used is able to inhibit in vitro growth and activity of FGO. New analogues with wider sst-affinity are now available for in vitro experim...